Vermeer B J, Staats C C, van Houwelingen J C
Academisch Ziekenhuis, afd. Huidziekten, Leiden.
Ned Tijdschr Geneeskd. 1996 Aug 3;140(31):1605-8.
To compare the efficacy of terbinafine cream during 1 week with the efficacy of miconazole cream during 4 weeks in the treatment of tinea pedis.
Prospective randomised double-blind study.
Department of dermatology, Academic Hospital Leiden, the Netherlands.
Patients who visited the general practitioner for tinea pedis and who had a positive KOH preparation were treated with terbinafine cream during 1 week and placebo during 3 weeks, or with miconazole cream during 4 weeks. Evaluation was done 1, 2, 3, 4 and 6 weeks after the start of the treatment. Mycological cure was defined as presence of a positive KOH preparation and a positive culture before treatment, and a negative result for both after treatment. Clinical efficacy was defined as mycological cure and presence of at most two minor symptoms (erythema, vesicles, squamae, itching) of the previously most serious skin lesion. Evaluation was done of all patients with a positive KOH preparation and of all patients with a positive KOH and a positive culture.
263 patients were included. Of these 207 had a positive culture; 56 patients had a positive KOH preparation but a negative culture. The group of patients treated with terbinafine and placebo consisted of 129 patients, the miconazole group of 134 patients. Both groups had an equal distribution as to age, sex, race, duration and seriousness of the fungal infection and previous treatment. Mycological cure and clinical efficacy throughout the evaluation were similar in both treatment groups, in both patients with positive KOH preparation and in patients with a positive KOH preparation and a positive culture. After 6 weeks mycological cure was seen in about 95% and clinical efficacy in about 87%.
In the treatment of tinea pedis local application of terbinafine cream during 1 week is as good as treatment with miconazole cream during 4 weeks.
比较特比萘芬乳膏治疗1周与咪康唑乳膏治疗4周在足癣治疗中的疗效。
前瞻性随机双盲研究。
荷兰莱顿学术医院皮肤科。
因足癣就诊于全科医生且KOH涂片检查呈阳性的患者,一组接受特比萘芬乳膏治疗1周,安慰剂治疗3周;另一组接受咪康唑乳膏治疗4周。在治疗开始后的1、2、3、4和6周进行评估。真菌学治愈定义为治疗前KOH涂片检查和培养均为阳性,治疗后两者均为阴性。临床疗效定义为真菌学治愈且之前最严重皮肤损害处至多存在两种轻微症状(红斑、水疱、鳞屑、瘙痒)。对所有KOH涂片检查呈阳性的患者以及所有KOH涂片检查和培养均呈阳性的患者进行评估。
纳入263例患者。其中207例培养呈阳性;56例KOH涂片检查呈阳性但培养呈阴性。接受特比萘芬和安慰剂治疗的患者组有129例,咪康唑组有134例。两组在年龄、性别、种族、真菌感染的持续时间和严重程度以及既往治疗方面分布均衡。在整个评估过程中,两个治疗组中KOH涂片检查呈阳性的患者以及KOH涂片检查和培养均呈阳性的患者,真菌学治愈和临床疗效相似。6周后,真菌学治愈率约为95%,临床有效率约为87%。
在足癣治疗中,局部应用特比萘芬乳膏1周与应用咪康唑乳膏4周的疗效相当。